Identifying genes that cause allergic airway inflammation using special mice
QTL mapping with Collaborative Cross mice defines genes that promote allergic airway inflammation
This study is looking at how certain genes affect asthma caused by allergens like mold, using a special group of mice to see how specific immune cells react to these allergens, which could help us find new ways to treat asthma.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11003280 on NIH RePORTER |
What this research studies
This research investigates how certain genes influence allergic airway inflammation, particularly in asthma triggered by allergens like mold. By using a unique group of genetically diverse mice, the study aims to understand how specific immune cells, known as ILC2, respond to allergens and contribute to inflammation in the lungs. The researchers will map genetic traits associated with the activation and proliferation of these immune cells when exposed to common environmental allergens. This approach could lead to new insights into the mechanisms of asthma and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from allergic asthma or related allergic conditions.
Not a fit: Patients with non-allergic asthma or those whose asthma is not influenced by genetic factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for asthma and allergic diseases by targeting the underlying genetic factors that drive inflammation.
How similar studies have performed: Previous research has shown success in using genetic mapping approaches to identify factors involved in asthma and allergic responses, indicating that this methodology is promising.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Rusznak, Mark — Vanderbilt University
- Study coordinator: Rusznak, Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.